nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—HRH1—atherosclerosis	0.464	1	CbGaD
Carbinoxamine—CYP2B6—Simvastatin—atherosclerosis	0.0397	0.0916	CbGbCtD
Carbinoxamine—CYP2C8—Simvastatin—atherosclerosis	0.03	0.0694	CbGbCtD
Carbinoxamine—CYP2C8—Lovastatin—atherosclerosis	0.0294	0.0679	CbGbCtD
Carbinoxamine—CYP2C8—Pravastatin—atherosclerosis	0.0294	0.0679	CbGbCtD
Carbinoxamine—CYP2C19—Rosuvastatin—atherosclerosis	0.0271	0.0626	CbGbCtD
Carbinoxamine—CYP2C19—Simvastatin—atherosclerosis	0.0252	0.0582	CbGbCtD
Carbinoxamine—CYP2C19—Lovastatin—atherosclerosis	0.0247	0.0569	CbGbCtD
Carbinoxamine—CYP2D6—Niacin—atherosclerosis	0.0242	0.056	CbGbCtD
Carbinoxamine—CYP2C9—Rosuvastatin—atherosclerosis	0.0225	0.052	CbGbCtD
Carbinoxamine—CYP2C9—Simvastatin—atherosclerosis	0.021	0.0484	CbGbCtD
Carbinoxamine—CYP2C9—Pravastatin—atherosclerosis	0.0205	0.0473	CbGbCtD
Carbinoxamine—CYP2C9—Lovastatin—atherosclerosis	0.0205	0.0473	CbGbCtD
Carbinoxamine—CYP2D6—Simvastatin—atherosclerosis	0.0192	0.0442	CbGbCtD
Carbinoxamine—CYP2D6—Pravastatin—atherosclerosis	0.0187	0.0433	CbGbCtD
Carbinoxamine—CYP2D6—Lovastatin—atherosclerosis	0.0187	0.0433	CbGbCtD
Carbinoxamine—CYP3A4—Rosuvastatin—atherosclerosis	0.0131	0.0303	CbGbCtD
Carbinoxamine—CYP3A4—Ezetimibe—atherosclerosis	0.0131	0.0303	CbGbCtD
Carbinoxamine—CYP3A4—Simvastatin—atherosclerosis	0.0122	0.0281	CbGbCtD
Carbinoxamine—CYP3A4—Pravastatin—atherosclerosis	0.0119	0.0275	CbGbCtD
Carbinoxamine—CYP3A4—Lovastatin—atherosclerosis	0.0119	0.0275	CbGbCtD
Carbinoxamine—Photosensitivity—Lovastatin—atherosclerosis	0.00114	0.0174	CcSEcCtD
Carbinoxamine—Photosensitivity—Ezetimibe—atherosclerosis	0.00112	0.0171	CcSEcCtD
Carbinoxamine—Haemolytic anaemia—Lovastatin—atherosclerosis	0.00111	0.017	CcSEcCtD
Carbinoxamine—Photosensitivity—Simvastatin—atherosclerosis	0.00106	0.0163	CcSEcCtD
Carbinoxamine—Haemolytic anaemia—Simvastatin—atherosclerosis	0.00103	0.0159	CcSEcCtD
Carbinoxamine—Photosensitivity—Pravastatin—atherosclerosis	0.000962	0.0148	CcSEcCtD
Carbinoxamine—Haemolytic anaemia—Pravastatin—atherosclerosis	0.000935	0.0143	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00089	0.0137	CcSEcCtD
Carbinoxamine—Diplopia—Pravastatin—atherosclerosis	0.000844	0.013	CcSEcCtD
Carbinoxamine—Urinary retention—Niacin—atherosclerosis	0.000816	0.0125	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000788	0.0121	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.000773	0.0119	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000754	0.0116	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00074	0.0114	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000737	0.0113	CcSEcCtD
Carbinoxamine—Sweating increased—Pravastatin—atherosclerosis	0.000711	0.0109	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000706	0.0108	CcSEcCtD
Carbinoxamine—Bepotastine—HRH1—atherosclerosis	0.00067	0.12	CrCbGaD
Carbinoxamine—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000666	0.0102	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000638	0.00979	CcSEcCtD
Carbinoxamine—Chills—Lovastatin—atherosclerosis	0.00062	0.00951	CcSEcCtD
Carbinoxamine—Confusional state—Rosuvastatin—atherosclerosis	0.000584	0.00896	CcSEcCtD
Carbinoxamine—Chills—Simvastatin—atherosclerosis	0.00058	0.00889	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000567	0.0087	CcSEcCtD
Carbinoxamine—Vision blurred—Lovastatin—atherosclerosis	0.000567	0.00869	CcSEcCtD
Carbinoxamine—Tremor—Lovastatin—atherosclerosis	0.000563	0.00864	CcSEcCtD
Carbinoxamine—Tinnitus—Niacin—atherosclerosis	0.000553	0.00849	CcSEcCtD
Carbinoxamine—Tinnitus—Pravastatin—atherosclerosis	0.000545	0.00836	CcSEcCtD
Carbinoxamine—Vertigo—Lovastatin—atherosclerosis	0.00054	0.00829	CcSEcCtD
Carbinoxamine—Chills—Niacin—atherosclerosis	0.000532	0.00817	CcSEcCtD
Carbinoxamine—Vision blurred—Simvastatin—atherosclerosis	0.00053	0.00813	CcSEcCtD
Carbinoxamine—Tremor—Simvastatin—atherosclerosis	0.000527	0.00808	CcSEcCtD
Carbinoxamine—Chills—Pravastatin—atherosclerosis	0.000524	0.00804	CcSEcCtD
Carbinoxamine—Insomnia—Rosuvastatin—atherosclerosis	0.000524	0.00804	CcSEcCtD
Carbinoxamine—Palpitations—Ezetimibe—atherosclerosis	0.000521	0.008	CcSEcCtD
Carbinoxamine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00052	0.00798	CcSEcCtD
Carbinoxamine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00051	0.00782	CcSEcCtD
Carbinoxamine—Tension—Niacin—atherosclerosis	0.000507	0.00778	CcSEcCtD
Carbinoxamine—Vertigo—Simvastatin—atherosclerosis	0.000505	0.00775	CcSEcCtD
Carbinoxamine—Nervousness—Niacin—atherosclerosis	0.000502	0.0077	CcSEcCtD
Carbinoxamine—Tension—Pravastatin—atherosclerosis	0.000499	0.00766	CcSEcCtD
Carbinoxamine—Constipation—Rosuvastatin—atherosclerosis	0.000495	0.0076	CcSEcCtD
Carbinoxamine—Confusional state—Lovastatin—atherosclerosis	0.000495	0.00759	CcSEcCtD
Carbinoxamine—Nervousness—Pravastatin—atherosclerosis	0.000494	0.00758	CcSEcCtD
Carbinoxamine—Vision blurred—Niacin—atherosclerosis	0.000487	0.00747	CcSEcCtD
Carbinoxamine—Chlorcyclizine—HRH1—atherosclerosis	0.000486	0.0872	CrCbGaD
Carbinoxamine—Confusional state—Ezetimibe—atherosclerosis	0.000485	0.00745	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000481	0.00737	CcSEcCtD
Carbinoxamine—Vision blurred—Pravastatin—atherosclerosis	0.000479	0.00735	CcSEcCtD
Carbinoxamine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000477	0.00732	CcSEcCtD
Carbinoxamine—Tremor—Pravastatin—atherosclerosis	0.000476	0.00731	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000471	0.00723	CcSEcCtD
Carbinoxamine—Anorexia—Lovastatin—atherosclerosis	0.000468	0.00718	CcSEcCtD
Carbinoxamine—Chloropyramine—HRH1—atherosclerosis	0.000468	0.0839	CrCbGaD
Carbinoxamine—Vertigo—Niacin—atherosclerosis	0.000464	0.00712	CcSEcCtD
Carbinoxamine—Confusional state—Simvastatin—atherosclerosis	0.000463	0.0071	CcSEcCtD
Carbinoxamine—Urticaria—Rosuvastatin—atherosclerosis	0.00046	0.00706	CcSEcCtD
Carbinoxamine—Vertigo—Pravastatin—atherosclerosis	0.000457	0.00701	CcSEcCtD
Carbinoxamine—Palpitations—Niacin—atherosclerosis	0.000456	0.007	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000449	0.0069	CcSEcCtD
Carbinoxamine—Dexbrompheniramine—HRH1—atherosclerosis	0.000446	0.08	CrCbGaD
Carbinoxamine—Insomnia—Lovastatin—atherosclerosis	0.000444	0.00681	CcSEcCtD
Carbinoxamine—Paraesthesia—Lovastatin—atherosclerosis	0.000441	0.00676	CcSEcCtD
Carbinoxamine—Anorexia—Simvastatin—atherosclerosis	0.000438	0.00671	CcSEcCtD
Carbinoxamine—Pheniramine—HRH1—atherosclerosis	0.000437	0.0783	CrCbGaD
Carbinoxamine—Insomnia—Ezetimibe—atherosclerosis	0.000435	0.00668	CcSEcCtD
Carbinoxamine—Paraesthesia—Ezetimibe—atherosclerosis	0.000432	0.00663	CcSEcCtD
Carbinoxamine—Dyspepsia—Lovastatin—atherosclerosis	0.000432	0.00663	CcSEcCtD
Carbinoxamine—Decreased appetite—Lovastatin—atherosclerosis	0.000427	0.00655	CcSEcCtD
Carbinoxamine—Dyspepsia—Ezetimibe—atherosclerosis	0.000424	0.0065	CcSEcCtD
Carbinoxamine—Fatigue—Lovastatin—atherosclerosis	0.000423	0.00649	CcSEcCtD
Carbinoxamine—Constipation—Lovastatin—atherosclerosis	0.00042	0.00644	CcSEcCtD
Carbinoxamine—Confusional state—Pravastatin—atherosclerosis	0.000419	0.00642	CcSEcCtD
Carbinoxamine—Decreased appetite—Ezetimibe—atherosclerosis	0.000418	0.00642	CcSEcCtD
Carbinoxamine—Asthenia—Rosuvastatin—atherosclerosis	0.000416	0.00637	CcSEcCtD
Carbinoxamine—Insomnia—Simvastatin—atherosclerosis	0.000415	0.00637	CcSEcCtD
Carbinoxamine—Fatigue—Ezetimibe—atherosclerosis	0.000415	0.00637	CcSEcCtD
Carbinoxamine—Paraesthesia—Simvastatin—atherosclerosis	0.000412	0.00632	CcSEcCtD
Carbinoxamine—Constipation—Ezetimibe—atherosclerosis	0.000412	0.00632	CcSEcCtD
Carbinoxamine—Tachycardia—Niacin—atherosclerosis	0.000411	0.00631	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Niacin—atherosclerosis	0.000408	0.00625	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000406	0.00623	CcSEcCtD
Carbinoxamine—Feeling abnormal—Lovastatin—atherosclerosis	0.000404	0.0062	CcSEcCtD
Carbinoxamine—Dyspepsia—Simvastatin—atherosclerosis	0.000404	0.0062	CcSEcCtD
Carbinoxamine—Anorexia—Niacin—atherosclerosis	0.000402	0.00616	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000401	0.00616	CcSEcCtD
Carbinoxamine—Decreased appetite—Simvastatin—atherosclerosis	0.000399	0.00612	CcSEcCtD
Carbinoxamine—Clofedanol—HRH1—atherosclerosis	0.000398	0.0713	CrCbGaD
Carbinoxamine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000397	0.00609	CcSEcCtD
Carbinoxamine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000396	0.00608	CcSEcCtD
Carbinoxamine—Fatigue—Simvastatin—atherosclerosis	0.000396	0.00607	CcSEcCtD
Carbinoxamine—Anorexia—Pravastatin—atherosclerosis	0.000396	0.00607	CcSEcCtD
Carbinoxamine—Hypotension—Niacin—atherosclerosis	0.000394	0.00604	CcSEcCtD
Carbinoxamine—Constipation—Simvastatin—atherosclerosis	0.000393	0.00602	CcSEcCtD
Carbinoxamine—Urticaria—Lovastatin—atherosclerosis	0.00039	0.00598	CcSEcCtD
Carbinoxamine—Dizziness—Rosuvastatin—atherosclerosis	0.000383	0.00588	CcSEcCtD
Carbinoxamine—Urticaria—Ezetimibe—atherosclerosis	0.000382	0.00587	CcSEcCtD
Carbinoxamine—Insomnia—Niacin—atherosclerosis	0.000381	0.00585	CcSEcCtD
Carbinoxamine—Paraesthesia—Niacin—atherosclerosis	0.000379	0.00581	CcSEcCtD
Carbinoxamine—Feeling abnormal—Simvastatin—atherosclerosis	0.000378	0.0058	CcSEcCtD
Carbinoxamine—Insomnia—Pravastatin—atherosclerosis	0.000375	0.00576	CcSEcCtD
Carbinoxamine—Somnolence—Niacin—atherosclerosis	0.000375	0.00575	CcSEcCtD
Carbinoxamine—Mepyramine—HRH1—atherosclerosis	0.000374	0.0671	CrCbGaD
Carbinoxamine—Paraesthesia—Pravastatin—atherosclerosis	0.000373	0.00572	CcSEcCtD
Carbinoxamine—Dyspepsia—Niacin—atherosclerosis	0.000371	0.00569	CcSEcCtD
Carbinoxamine—Decreased appetite—Niacin—atherosclerosis	0.000366	0.00562	CcSEcCtD
Carbinoxamine—Dyspepsia—Pravastatin—atherosclerosis	0.000365	0.0056	CcSEcCtD
Carbinoxamine—Urticaria—Simvastatin—atherosclerosis	0.000365	0.00559	CcSEcCtD
Carbinoxamine—Doxylamine—HRH1—atherosclerosis	0.000364	0.0652	CrCbGaD
Carbinoxamine—Headache—Rosuvastatin—atherosclerosis	0.000363	0.00557	CcSEcCtD
Carbinoxamine—Decreased appetite—Pravastatin—atherosclerosis	0.000361	0.00553	CcSEcCtD
Carbinoxamine—Fatigue—Pravastatin—atherosclerosis	0.000358	0.00549	CcSEcCtD
Carbinoxamine—Constipation—Pravastatin—atherosclerosis	0.000355	0.00544	CcSEcCtD
Carbinoxamine—Asthenia—Lovastatin—atherosclerosis	0.000352	0.0054	CcSEcCtD
Carbinoxamine—Tripelennamine—HRH1—atherosclerosis	0.000346	0.062	CrCbGaD
Carbinoxamine—Asthenia—Ezetimibe—atherosclerosis	0.000345	0.0053	CcSEcCtD
Carbinoxamine—Nausea—Rosuvastatin—atherosclerosis	0.000344	0.00528	CcSEcCtD
Carbinoxamine—Feeling abnormal—Pravastatin—atherosclerosis	0.000342	0.00525	CcSEcCtD
Carbinoxamine—Diarrhoea—Lovastatin—atherosclerosis	0.000336	0.00515	CcSEcCtD
Carbinoxamine—Urticaria—Niacin—atherosclerosis	0.000335	0.00514	CcSEcCtD
Carbinoxamine—Urticaria—Pravastatin—atherosclerosis	0.00033	0.00506	CcSEcCtD
Carbinoxamine—Asthenia—Simvastatin—atherosclerosis	0.000329	0.00505	CcSEcCtD
Carbinoxamine—Diarrhoea—Ezetimibe—atherosclerosis	0.000329	0.00505	CcSEcCtD
Carbinoxamine—Dizziness—Lovastatin—atherosclerosis	0.000325	0.00498	CcSEcCtD
Carbinoxamine—Dizziness—Ezetimibe—atherosclerosis	0.000318	0.00488	CcSEcCtD
Carbinoxamine—Dimetindene—HRH1—atherosclerosis	0.000318	0.057	CrCbGaD
Carbinoxamine—Diarrhoea—Simvastatin—atherosclerosis	0.000314	0.00482	CcSEcCtD
Carbinoxamine—Vomiting—Lovastatin—atherosclerosis	0.000312	0.00479	CcSEcCtD
Carbinoxamine—Headache—Lovastatin—atherosclerosis	0.000307	0.00472	CcSEcCtD
Carbinoxamine—Vomiting—Ezetimibe—atherosclerosis	0.000306	0.0047	CcSEcCtD
Carbinoxamine—Dizziness—Simvastatin—atherosclerosis	0.000304	0.00466	CcSEcCtD
Carbinoxamine—Asthenia—Niacin—atherosclerosis	0.000302	0.00464	CcSEcCtD
Carbinoxamine—Headache—Ezetimibe—atherosclerosis	0.000302	0.00463	CcSEcCtD
Carbinoxamine—Asthenia—Pravastatin—atherosclerosis	0.000298	0.00457	CcSEcCtD
Carbinoxamine—Vomiting—Simvastatin—atherosclerosis	0.000292	0.00448	CcSEcCtD
Carbinoxamine—Nausea—Lovastatin—atherosclerosis	0.000292	0.00447	CcSEcCtD
Carbinoxamine—Diarrhoea—Niacin—atherosclerosis	0.000288	0.00442	CcSEcCtD
Carbinoxamine—Headache—Simvastatin—atherosclerosis	0.000288	0.00441	CcSEcCtD
Carbinoxamine—Nausea—Ezetimibe—atherosclerosis	0.000286	0.00439	CcSEcCtD
Carbinoxamine—Bromodiphenhydramine—HRH1—atherosclerosis	0.000284	0.051	CrCbGaD
Carbinoxamine—Diarrhoea—Pravastatin—atherosclerosis	0.000284	0.00436	CcSEcCtD
Carbinoxamine—Dizziness—Niacin—atherosclerosis	0.000279	0.00428	CcSEcCtD
Carbinoxamine—Dizziness—Pravastatin—atherosclerosis	0.000274	0.00421	CcSEcCtD
Carbinoxamine—Nausea—Simvastatin—atherosclerosis	0.000273	0.00418	CcSEcCtD
Carbinoxamine—Vomiting—Niacin—atherosclerosis	0.000268	0.00411	CcSEcCtD
Carbinoxamine—Headache—Niacin—atherosclerosis	0.000264	0.00405	CcSEcCtD
Carbinoxamine—Vomiting—Pravastatin—atherosclerosis	0.000264	0.00405	CcSEcCtD
Carbinoxamine—Headache—Pravastatin—atherosclerosis	0.00026	0.00399	CcSEcCtD
Carbinoxamine—Nausea—Niacin—atherosclerosis	0.00025	0.00384	CcSEcCtD
Carbinoxamine—Nausea—Pravastatin—atherosclerosis	0.000247	0.00378	CcSEcCtD
Carbinoxamine—Brompheniramine—HRH1—atherosclerosis	0.000205	0.0367	CrCbGaD
Carbinoxamine—Chlorphenamine—HRH1—atherosclerosis	0.000201	0.0361	CrCbGaD
Carbinoxamine—Chlorprothixene—HRH1—atherosclerosis	0.00015	0.027	CrCbGaD
Carbinoxamine—Diphenhydramine—HRH1—atherosclerosis	0.000136	0.0245	CrCbGaD
Carbinoxamine—Orphenadrine—HRH1—atherosclerosis	0.000129	0.0231	CrCbGaD
Carbinoxamine—Chlorpromazine—HRH1—atherosclerosis	0.000104	0.0186	CrCbGaD
Carbinoxamine—Clomipramine—ALB—atherosclerosis	3.49e-05	0.00625	CrCbGaD
Carbinoxamine—Chlorpromazine—ALB—atherosclerosis	2.39e-05	0.00429	CrCbGaD
Carbinoxamine—CYP2C8—Metabolism—CETP—atherosclerosis	8.73e-06	0.000268	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	8.63e-06	0.000265	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	8.63e-06	0.000265	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	8.55e-06	0.000262	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—F2—atherosclerosis	8.53e-06	0.000262	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	8.45e-06	0.000259	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	8.38e-06	0.000257	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.37e-06	0.000257	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	8.36e-06	0.000256	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—SCARB1—atherosclerosis	8.36e-06	0.000256	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ALOX5—atherosclerosis	8.33e-06	0.000255	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ABCA1—atherosclerosis	8.31e-06	0.000255	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ALOX5—atherosclerosis	8.26e-06	0.000253	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PIK3CG—atherosclerosis	8.17e-06	0.00025	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ABCA1—atherosclerosis	8.14e-06	0.00025	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.14e-06	0.000249	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—NAMPT—atherosclerosis	8.12e-06	0.000249	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.08e-06	0.000248	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—LIPC—atherosclerosis	8.07e-06	0.000248	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ABCG1—atherosclerosis	8.06e-06	0.000247	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—APOC3—atherosclerosis	8.02e-06	0.000246	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—LDLR—atherosclerosis	7.97e-06	0.000245	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—HMGCR—atherosclerosis	7.89e-06	0.000242	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KNG1—atherosclerosis	7.8e-06	0.000239	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CETP—atherosclerosis	7.79e-06	0.000239	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AGTR1—atherosclerosis	7.75e-06	0.000238	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	7.63e-06	0.000234	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—CCL2—atherosclerosis	7.61e-06	0.000233	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LCAT—atherosclerosis	7.58e-06	0.000232	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—FABP4—atherosclerosis	7.58e-06	0.000232	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PLG—atherosclerosis	7.56e-06	0.000232	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—NAMPT—atherosclerosis	7.47e-06	0.000229	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—SCARB1—atherosclerosis	7.46e-06	0.000229	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOA4—atherosclerosis	7.44e-06	0.000228	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—LIPC—atherosclerosis	7.42e-06	0.000228	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—NAMPT—atherosclerosis	7.41e-06	0.000227	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—APOC3—atherosclerosis	7.38e-06	0.000226	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	7.36e-06	0.000226	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—LIPC—atherosclerosis	7.36e-06	0.000226	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—LDLR—atherosclerosis	7.33e-06	0.000225	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—APOC3—atherosclerosis	7.32e-06	0.000224	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	7.31e-06	0.000224	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—LDLR—atherosclerosis	7.27e-06	0.000223	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.26e-06	0.000223	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CETP—atherosclerosis	7.16e-06	0.00022	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SOCS3—atherosclerosis	7.15e-06	0.000219	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—HMOX1—atherosclerosis	7.13e-06	0.000219	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.12e-06	0.000218	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CETP—atherosclerosis	7.1e-06	0.000218	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—HMGCR—atherosclerosis	7.04e-06	0.000216	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ABCA1—atherosclerosis	7.03e-06	0.000216	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—HMOX1—atherosclerosis	6.98e-06	0.000214	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MMP3—atherosclerosis	6.91e-06	0.000212	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IGF2—atherosclerosis	6.88e-06	0.000211	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—SCARB1—atherosclerosis	6.86e-06	0.00021	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—APOB—atherosclerosis	6.83e-06	0.000209	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—SCARB1—atherosclerosis	6.8e-06	0.000209	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	6.76e-06	0.000207	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—APOB—atherosclerosis	6.69e-06	0.000205	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—APOB—atherosclerosis	6.68e-06	0.000205	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GSTM1—atherosclerosis	6.64e-06	0.000204	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—CXCL8—atherosclerosis	6.62e-06	0.000203	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.62e-06	0.000203	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—EDN1—atherosclerosis	6.57e-06	0.000202	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCL5—atherosclerosis	6.52e-06	0.0002	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—LPL—atherosclerosis	6.52e-06	0.0002	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GSTM1—atherosclerosis	6.51e-06	0.000199	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—HMGCR—atherosclerosis	6.48e-06	0.000199	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—HMGCR—atherosclerosis	6.42e-06	0.000197	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	6.41e-06	0.000196	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALOX15—atherosclerosis	6.41e-06	0.000196	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	6.41e-06	0.000196	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOA2—atherosclerosis	6.41e-06	0.000196	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—LPL—atherosclerosis	6.39e-06	0.000196	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—LPL—atherosclerosis	6.38e-06	0.000196	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GPX1—atherosclerosis	6.36e-06	0.000195	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.35e-06	0.000195	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ABCG5—atherosclerosis	6.33e-06	0.000194	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ABCA1—atherosclerosis	6.28e-06	0.000193	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GPX1—atherosclerosis	6.23e-06	0.000191	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PRKCG—atherosclerosis	6.2e-06	0.00019	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CD36—atherosclerosis	6.19e-06	0.00019	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LPA—atherosclerosis	6.11e-06	0.000187	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CD36—atherosclerosis	6.07e-06	0.000186	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SPP1—atherosclerosis	6.04e-06	0.000185	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—HMOX1—atherosclerosis	6.03e-06	0.000185	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—CXCL8—atherosclerosis	6.01e-06	0.000184	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—BGN—atherosclerosis	5.92e-06	0.000181	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—MTHFR—atherosclerosis	5.87e-06	0.00018	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOA5—atherosclerosis	5.86e-06	0.00018	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.79e-06	0.000178	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—APOB—atherosclerosis	5.78e-06	0.000177	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ABCA1—atherosclerosis	5.77e-06	0.000177	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PPARA—atherosclerosis	5.76e-06	0.000177	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—MTHFR—atherosclerosis	5.75e-06	0.000176	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ABCA1—atherosclerosis	5.72e-06	0.000176	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PPARA—atherosclerosis	5.64e-06	0.000173	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	5.64e-06	0.000173	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GSTM1—atherosclerosis	5.62e-06	0.000172	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PDGFB—atherosclerosis	5.59e-06	0.000171	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—AGT—atherosclerosis	5.58e-06	0.000171	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—LPL—atherosclerosis	5.52e-06	0.000169	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—APOE—atherosclerosis	5.46e-06	0.000168	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—AGT—atherosclerosis	5.46e-06	0.000168	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AGT—atherosclerosis	5.46e-06	0.000167	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALOX5—atherosclerosis	5.45e-06	0.000167	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CAV1—atherosclerosis	5.41e-06	0.000166	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—APOA1—atherosclerosis	5.4e-06	0.000166	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—HMOX1—atherosclerosis	5.39e-06	0.000165	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GPX1—atherosclerosis	5.38e-06	0.000165	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—APOE—atherosclerosis	5.35e-06	0.000164	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—LEP—atherosclerosis	5.35e-06	0.000164	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—APOE—atherosclerosis	5.35e-06	0.000164	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CAV1—atherosclerosis	5.3e-06	0.000163	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CAV1—atherosclerosis	5.3e-06	0.000162	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—APOA1—atherosclerosis	5.29e-06	0.000162	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—APOA1—atherosclerosis	5.28e-06	0.000162	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CD36—atherosclerosis	5.24e-06	0.000161	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—APOB—atherosclerosis	5.16e-06	0.000158	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ESR1—atherosclerosis	5.1e-06	0.000157	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—F2—atherosclerosis	5.04e-06	0.000155	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GSTM1—atherosclerosis	5.02e-06	0.000154	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—MTHFR—atherosclerosis	4.97e-06	0.000152	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—HMOX1—atherosclerosis	4.95e-06	0.000152	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CG—atherosclerosis	4.93e-06	0.000151	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—LPL—atherosclerosis	4.93e-06	0.000151	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—HMOX1—atherosclerosis	4.91e-06	0.000151	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NAMPT—atherosclerosis	4.89e-06	0.00015	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PPARA—atherosclerosis	4.88e-06	0.00015	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LIPC—atherosclerosis	4.85e-06	0.000149	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CG—atherosclerosis	4.83e-06	0.000148	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOC3—atherosclerosis	4.82e-06	0.000148	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CG—atherosclerosis	4.82e-06	0.000148	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GPX1—atherosclerosis	4.81e-06	0.000147	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LDLR—atherosclerosis	4.8e-06	0.000147	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PPARG—atherosclerosis	4.76e-06	0.000146	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—APOB—atherosclerosis	4.75e-06	0.000146	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—AGT—atherosclerosis	4.72e-06	0.000145	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—APOB—atherosclerosis	4.7e-06	0.000144	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CETP—atherosclerosis	4.68e-06	0.000144	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CD36—atherosclerosis	4.68e-06	0.000144	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—INS—atherosclerosis	4.67e-06	0.000143	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PPARG—atherosclerosis	4.66e-06	0.000143	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—APOE—atherosclerosis	4.63e-06	0.000142	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—MAPK3—atherosclerosis	4.62e-06	0.000142	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GSTM1—atherosclerosis	4.62e-06	0.000142	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CAV1—atherosclerosis	4.58e-06	0.000141	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTM1—atherosclerosis	4.58e-06	0.00014	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—APOA1—atherosclerosis	4.57e-06	0.00014	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—INS—atherosclerosis	4.57e-06	0.00014	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—INS—atherosclerosis	4.57e-06	0.00014	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—LPL—atherosclerosis	4.53e-06	0.000139	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCL2—atherosclerosis	4.49e-06	0.000138	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—LPL—atherosclerosis	4.49e-06	0.000138	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SCARB1—atherosclerosis	4.49e-06	0.000138	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—MTHFR—atherosclerosis	4.44e-06	0.000136	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GPX1—atherosclerosis	4.42e-06	0.000136	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IGF1—atherosclerosis	4.42e-06	0.000135	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GPX1—atherosclerosis	4.38e-06	0.000134	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PPARA—atherosclerosis	4.35e-06	0.000133	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CD36—atherosclerosis	4.31e-06	0.000132	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ALB—atherosclerosis	4.28e-06	0.000131	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CD36—atherosclerosis	4.27e-06	0.000131	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.24e-06	0.00013	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—AGT—atherosclerosis	4.21e-06	0.000129	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	4.19e-06	0.000129	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ALB—atherosclerosis	4.19e-06	0.000129	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CG—atherosclerosis	4.18e-06	0.000128	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—APOE—atherosclerosis	4.13e-06	0.000127	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—NOS3—atherosclerosis	4.09e-06	0.000126	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CAV1—atherosclerosis	4.09e-06	0.000125	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—APOA1—atherosclerosis	4.08e-06	0.000125	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—MTHFR—atherosclerosis	4.08e-06	0.000125	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.04e-06	0.000124	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PPARG—atherosclerosis	4.03e-06	0.000124	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—NOS3—atherosclerosis	4.01e-06	0.000123	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NOS3—atherosclerosis	4e-06	0.000123	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PPARA—atherosclerosis	4e-06	0.000123	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PPARA—atherosclerosis	3.97e-06	0.000122	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—INS—atherosclerosis	3.95e-06	0.000121	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AGT—atherosclerosis	3.88e-06	0.000119	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AGT—atherosclerosis	3.84e-06	0.000118	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—APOE—atherosclerosis	3.8e-06	0.000116	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.78e-06	0.000116	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—APOE—atherosclerosis	3.77e-06	0.000115	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CAV1—atherosclerosis	3.76e-06	0.000115	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—APOA1—atherosclerosis	3.75e-06	0.000115	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PTGS2—atherosclerosis	3.74e-06	0.000115	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CAV1—atherosclerosis	3.73e-06	0.000114	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	3.73e-06	0.000114	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—APOA1—atherosclerosis	3.72e-06	0.000114	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PTGS2—atherosclerosis	3.67e-06	0.000112	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ALB—atherosclerosis	3.62e-06	0.000111	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PPARG—atherosclerosis	3.6e-06	0.00011	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	3.55e-06	0.000109	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—INS—atherosclerosis	3.53e-06	0.000108	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—NOS3—atherosclerosis	3.47e-06	0.000106	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	3.43e-06	0.000105	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	3.43e-06	0.000105	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.4e-06	0.000104	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL6—atherosclerosis	3.38e-06	0.000104	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PPARG—atherosclerosis	3.31e-06	0.000101	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PPARG—atherosclerosis	3.28e-06	0.000101	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—INS—atherosclerosis	3.24e-06	9.95e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.24e-06	9.93e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ALB—atherosclerosis	3.23e-06	9.92e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—INS—atherosclerosis	3.22e-06	9.86e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MMP9—atherosclerosis	3.21e-06	9.85e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	3.18e-06	9.75e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PTGS2—atherosclerosis	3.17e-06	9.72e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	3.12e-06	9.58e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	3.12e-06	9.56e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOB—atherosclerosis	3.1e-06	9.51e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—NOS3—atherosclerosis	3.09e-06	9.49e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.02e-06	9.26e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ALB—atherosclerosis	2.97e-06	9.12e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LPL—atherosclerosis	2.96e-06	9.08e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ALB—atherosclerosis	2.95e-06	9.04e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GPX1—atherosclerosis	2.89e-06	8.86e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	2.89e-06	8.85e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—STAT3—atherosclerosis	2.86e-06	8.76e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—NOS3—atherosclerosis	2.85e-06	8.73e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PTGS2—atherosclerosis	2.83e-06	8.68e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—NOS3—atherosclerosis	2.82e-06	8.65e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CD36—atherosclerosis	2.81e-06	8.63e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	2.73e-06	8.37e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.67e-06	8.18e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	2.65e-06	8.12e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPARA—atherosclerosis	2.62e-06	8.02e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.6e-06	7.98e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.58e-06	7.91e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AGT—atherosclerosis	2.53e-06	7.77e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOE—atherosclerosis	2.48e-06	7.61e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CAV1—atherosclerosis	2.46e-06	7.54e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOA1—atherosclerosis	2.45e-06	7.53e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.24e-06	6.87e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPARG—atherosclerosis	2.16e-06	6.63e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—INS—atherosclerosis	2.12e-06	6.51e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6—atherosclerosis	2e-06	6.12e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALB—atherosclerosis	1.94e-06	5.96e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—AKT1—atherosclerosis	1.88e-06	5.77e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NOS3—atherosclerosis	1.86e-06	5.7e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—AKT1—atherosclerosis	1.84e-06	5.65e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKT1—atherosclerosis	1.84e-06	5.65e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.7e-06	5.22e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—AKT1—atherosclerosis	1.59e-06	4.89e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—AKT1—atherosclerosis	1.42e-06	4.36e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.31e-06	4.01e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AKT1—atherosclerosis	1.3e-06	3.98e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AKT1—atherosclerosis	8.55e-07	2.62e-05	CbGpPWpGaD
